Efficacy of albaconazole against Candida albicans in a vaginitis model
- PMID: 19635949
- PMCID: PMC2764185
- DOI: 10.1128/AAC.00565-09
Efficacy of albaconazole against Candida albicans in a vaginitis model
Abstract
The efficacy of albaconazole (ABC) was evaluated using a murine model of vaginal Candida albicans infection. Both ABC and fluconazole (FLC) were effective in reducing the fungal load from vaginas of infected mice; however, ABC demonstrated encouraging activities against an FLC-resistant strain, with trends toward superiority over FLC in some treatment groups.
Similar articles
-
Efficacy of ravuconazole in a murine model of vaginitis by Candida albicans.Rev Iberoam Micol. 2015 Jan-Mar;32(1):30-3. doi: 10.1016/j.riam.2013.09.006. Epub 2013 Sep 23. Rev Iberoam Micol. 2015. PMID: 24071640
-
Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model.Med Mycol. 2007 May;45(3):221-4. doi: 10.1080/13693780601164298. Med Mycol. 2007. PMID: 17464843
-
Therapeutic efficacy of posaconazole against Candida glabrata in a murine model of vaginitis.Mycoses. 2011 Mar;54(2):119-22. doi: 10.1111/j.1439-0507.2009.01775.x. Mycoses. 2011. PMID: 19811615
-
Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery.Int J Antimicrob Agents. 2014 May;43(5):395-402. doi: 10.1016/j.ijantimicag.2013.12.009. Epub 2014 Jan 22. Int J Antimicrob Agents. 2014. PMID: 24503221 Review.
-
Candida vaginitis: when opportunism knocks, the host responds.PLoS Pathog. 2014 Apr 3;10(4):e1003965. doi: 10.1371/journal.ppat.1003965. eCollection 2014 Apr. PLoS Pathog. 2014. PMID: 24699903 Free PMC article. Review. No abstract available.
Cited by
-
A non-antibiotic antimicrobial drug, a biological bacteriostatic agent, is useful for treating aerobic vaginitis, bacterial vaginosis, and vulvovaginal candidiasis.Front Microbiol. 2024 May 27;15:1341878. doi: 10.3389/fmicb.2024.1341878. eCollection 2024. Front Microbiol. 2024. PMID: 38860217 Free PMC article.
References
-
- Calderon, L., R. Williams, M. Martinez, K. V. Clemons, and D. A. Stevens. 2003. Genetic susceptibility to vaginal candidiasis. Med. Mycol. 41:143-147. - PubMed
-
- González, G. M., E. Robledo, D. Saldívar, G. González, F. Bosques, and E. Garza. 2007. Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model. Med. Mycol. 45:221-224. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical